Refractory urticarial vasculitis responsive to anti-B-cell therapy

British Journal of Dermatology

Volumn 160, Issue 2, 2009, Pages 470-472

  Mukhtyar, C ^a   Misbah, S ^b   Wilkinson, J ^c   Wordsworth, P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c WYCOMBE HOSPITAL   (United Kingdom)

Author keywords

Immunoglobulin E; Immunoglobulin E receptor; Rituximab; Urticaria

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CYCLOSPORIN A; DAPSONE; IMMUNOGLOBULIN E; METHOTREXATE; PENTOXIFYLLINE; PREDNISOLONE; RITUXIMAB; TRANEXAMIC ACID;

ADULT; ANAMNESIS; ANGIONEUROTIC EDEMA; AUTOIMMUNE DISEASE; CASE REPORT; CELL THERAPY; CLINICAL FEATURE; CONTINUOUS INFUSION; DRUG DOSE TITRATION; FEMALE; HISTAMINE RELEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; PLASMAPHERESIS; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT RESPONSE; URTICARIA; VASCULITIS;

ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; URTICARIA; VASCULITIS, HYPERSENSITIVITY;

EID: 58349107049     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08990.x     Document Type: Letter

References (9)

1. Platzer MH, Grattan CE, Poulsen LK, Skov PS. Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients. Allergy 2005 60 : 1152 6.
2. Fiebiger E, Maurer D, Holub H et al. Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 1995 96 : 2606 12.
3. Hide M, Francis DM, Grattan CE et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993 328 : 1599 604.
4. Tong LJ, Balakrishnan G, Kochan JP et al. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997 99 : 461 5.
5. Carr DR, Heffernan MP. Off-label uses of rituximab in dermatology. Dermatol Ther 2007 20 : 277 87.
6. Walsh M, Jayne D. Rituximab in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis and systemic lupus erythematosus: past, present and future. Kidney Int 2007 72 : 676 82.
7. Furst DE, Breedveld FC, Kalden JR et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007. Ann Rheum Dis 2007 66 (Suppl. 3 iii2 22.
8. Garvey B. Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol 2008 141 : 149 69.
9. Mallipeddi R, Grattan CE. Lack of response of severe steroid-dependent chronic urticaria to rituximab. Clin Exp Dermatol 2007 32 : 333 4.